Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Turk J Pediatr ; 62(6): 1069-1076, 2020.
Article in English | MEDLINE | ID: mdl-33372447

ABSTRACT

BACKGROUND: Acute kidney injury (AKI) is a common condition in the neonatal intensive care unit (NICU), particularly in preterm infants. Management of AKI in neonates is challenging. Peritoneal dialysis (PD) has been preferred as the most applicable modality in neonates when medical therapy fails. CASE: A female infant was born at 24 and 4/7 weeks with a birth weight of 460 grams after an emergency cesarian section from a preeclamptic pregnacy. She developed AKI secondary to sepsis. A neonatal, straight single-cuff Tenckhoff catheter was inserted and PD was started on day 12. PD was discontinued after 6 days, on day 18 with adequate urine output and normalization of kidney function tests. However, the patient died on day 152 secondary to a nosocomial infection. CONCLUSION: To the best of our knowlegde, our case is the smallest infant in whom PD was performed succesfully with a PD catheter. PD is a relatively safe, effective and a feasible therapy in the neonatal population even in the smallest infants. PD may be a live-saving procedure in extremely low birth weight infants with severe AKI.


Subject(s)
Infant, Extremely Low Birth Weight , Peritoneal Dialysis , Female , Humans , Infant , Infant, Newborn , Infant, Premature , Intensive Care Units, Neonatal , Peritoneal Dialysis/adverse effects , Pregnancy , Retrospective Studies
2.
Am J Perinatol ; 31(12): 1043-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24584998

ABSTRACT

OBJECTIVE: Systemic fungal infections are major causes of morbidity and mortality, and are associated with significant neurodevelopmental impairment in premature infants. Our objective was to evaluate the efficacy of fluconazole prophylaxis in prevention of systemic fungal infections among preterm infants. STUDY DESIGN: This observational pre-post cohort study was performed in preterm infants with a birth weight of < 1,000 g who were given prophylactic fluconazole starting on the first postnatal day at a dose of 3 mg/kg twice a week. These infants were compared with preterm infants who were not given prophylaxis. RESULTS: Prophylaxis group consisted of 90 infants and control group consisted of 107 infants. Systemic fungal infection was observed in five patients (4.7%) in the control group while no fungal infection was detected in the prophylaxis group (p = 0.03). There were no significant differences between two groups in terms of demographic features, maternal and neonatal risk factors, and all-cause mortality rates. No adverse reactions were seen during the prophylaxis period. CONCLUSIONS: We suggest that intravenous fluconazole prophylaxis at a dose of 3 mg/kg twice a week is a safe and effective strategy for decreasing systemic fungal infections even in neonatal intensive care units with low rates of invasive Candida infection.


Subject(s)
Antifungal Agents/therapeutic use , Birth Weight , Candidiasis, Invasive/prevention & control , Fluconazole/therapeutic use , Infant, Extremely Low Birth Weight , Infant, Premature, Diseases/prevention & control , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature , Intensive Care, Neonatal , Male , Premature Birth
3.
Vaccine ; 31(38): 4172-6, 2013 Aug 28.
Article in English | MEDLINE | ID: mdl-23845808

ABSTRACT

BACKGROUND: The resurgence of pertussis has resulted in an increased morbidity and mortality, especially among young infants. The aim of our study was to determine the antibody concentrations against pertussis antigens in cord and maternal blood in both preterm and term infant-mother pairs and to evaluate the efficacy of transplacental antibody transfer. METHODS: Antibodies to pertussis toxin (PT) and filamentous hemagglutinin (FHA) in maternal and cord blood samples were measured by in-house enzyme linked immunosorbent assay (ELISA) in 100 preterm infant-mother and 100 term infant-mother pairs. Geometric mean concentrations (GMCs) of pertussis antibodies and cord:maternal GMC ratios were calculated. RESULTS: Cord GMCs for anti-PT and anti-FHA in the preterm group were 13.15 and 14.55 ELISA U/ml (EU/ml), respectively. Cord GMCs for anti-PT and anti-FHA in the term group were 19.46 and 19.18 EU/ml, respectively. Cord anti-PT GMC was significanlty lower in the preterm group (p=0.037). There were no differences between the groups with regard to maternal anti-PT and anti-FHA GMC. Placental transfer ratios for anti-PT and anti-FHA in preterms were 68% and 72%, respectively. The same ratios in terms were 107% and 120%, respectively and were significantly higher than those of preterms (p<0.001). Placental transfer ratios were even lower in preterms <32 weeks when compared to preterms ≥32 weeks and terms. There was a strong correlation between maternal and cord anti-pertussis antibody levels both in preterm and term infants. CONCLUSIONS: Anti-pertussis antibody levels were generally low in infant-mother pairs and would not be adequate to confer protection until the onset of primary immunization series. Transplacental anti-pertussis antibody transfers and antibody levels were lower in the cord blood of preterm infants, especially in those <32 weeks. These findings support the rationale for maternal immunization, which in combination with cocooning, could be a better option for preterm infants.


Subject(s)
Antibodies, Bacterial/blood , Fetal Blood/immunology , Fetal Blood/microbiology , Infant, Premature/immunology , Whooping Cough/immunology , Adhesins, Bacterial/immunology , Adult , Birth Weight , Female , Humans , Infant, Newborn , Pertussis Toxin/immunology , Seroepidemiologic Studies , Virulence Factors, Bordetella/immunology , Young Adult
4.
J Child Neurol ; 28(1): 115-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22451530

ABSTRACT

Macrocephaly-capillary malformation syndrome is characterized by cutaneous vascular malformations with associated anomalies as macrocephaly, macrosomia, hemihypertrophy, hypotonia, developmental delay, lax joints, loose skin, polysyndactyly, and neuroimaging abnormalities. We present a newborn with a prenatal diagnosis of macrosomia and tetralogy of Fallot. He also had macrocephaly; a high forehead; capillary hemangioma on the forehead, upper lip, and philtrum; generalized loose skin; postaxial polydactyly of both hands and feet, with neuroimaging findings of polymicrogyria and thrombosis in sagittal sinus and sinus rectus. His condition was diagnosed as macrocephaly-capillary malformation syndrome in the neonatal period and he died suddenly during sleep at 6 months of age. The clinical course in this syndrome is not as benign as was previously thought. Careful follow-up of these patients with particular emphasis on neuroradiologic and cardiologic evaluation might help decrease the risk of sudden death and to improve long-term outcome.


Subject(s)
Megalencephaly/etiology , Sagittal Sinus Thrombosis/complications , Skin Abnormalities/etiology , Tetralogy of Fallot/complications , Brain/pathology , Humans , Infant , Magnetic Resonance Imaging , Male , Megalencephaly/complications , Skin Abnormalities/complications
6.
J Child Neurol ; 23(11): 1312-5, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18984842

ABSTRACT

Spontaneous intracranial hypotension is a rare syndrome of low cerebrospinal fluid pressure due to spontaneous cerebrospinal fluid leaks. The main feature is orthostatic headache. We describe a case of spontaneous intracranial hypotension in a 5-year-old girl with a 1-month history of headache, sudden onset hearing loss, and ataxia. Magnetic resonance imaging (MRI) showed an enlargement of cervical venous plexus and lumbar puncture revealed a low opening pressure. Magnetic resonance myelography showed leakage of the contrast material at the level of the third and fourth lumbar vertebra. Bed rest and caffeine treatment yielded no resolution of symptoms. Following a lumbar epidural blood patch, her headache and ataxia resolved completely without any improvement in hearing. A second blood patch also yielded no effect on hearing. Spontaneous intracranial hypotension should be considered in the differential diagnosis of headache, also in the pediatric age group.


Subject(s)
Intracranial Hypotension/complications , Intracranial Hypotension/diagnosis , Brain/pathology , Child, Preschool , Female , Humans , Magnetic Resonance Imaging/methods , Spinal Cord/pathology
7.
J Child Neurol ; 23(3): 338-40, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18079308

ABSTRACT

It has been demonstrated that obsessive-compulsive disease and/or tic syndromes in children may be triggered by an antecedent infection especially with group A beta-hemolytic streptococci, and this subgroup of children has been designated by the acronym PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections). Other infectious agents such as viruses and bacteria have also been reported to be associated with the acute onset or dramatic exacerbation of obsessive-compulsive disease or Tourette syndrome, and another acronym, PITAND (pediatric infection-triggered autoimmune neuropsychiatric disorder) has appeared in the literature. The involvement of other infectious agents such as Mycoplasma pneumoniae has been described in single case reports. We describe a case of a 5.5-year-old boy who suddenly developed obsessive-compulsive disease symptoms during a M. pneumoniae pneumonia. After treatment with oral clarithromycin, all his obsessive-compulsive disease symptoms disappeared. To our knowledge, this is the first report that shows the association between Mycoplasma pneumoniae infection and obsessive-compulsive disease.


Subject(s)
Autoimmune Diseases/complications , Obsessive-Compulsive Disorder/complications , Pneumonia, Mycoplasma/complications , Urination Disorders/psychology , Anti-Bacterial Agents/therapeutic use , Autoimmune Diseases/microbiology , Child, Preschool , Clarithromycin/therapeutic use , Humans , Male , Mycoplasma pneumoniae , Obsessive-Compulsive Disorder/immunology , Pneumonia, Mycoplasma/drug therapy , Pneumonia, Mycoplasma/psychology , Syndrome , Treatment Outcome , Urination Disorders/etiology
8.
J Pediatr Hematol Oncol ; 27(5): 273-7, 2005 May.
Article in English | MEDLINE | ID: mdl-15891564

ABSTRACT

The objective of this study was to investigate the diphtheria-tetanus-pertussis and/or measles-mumps antibody titers before and after vaccination at various time points of acute lymphoblastic leukemia (ALL) therapy and to suggest an appropriate vaccination approach for ALL patients. The authors studied 37 ALL patients and 14 healthy control subjects, divided into three groups. In group 1 (newly diagnosed patients), baseline anti-diphtheria, anti-tetanus, and anti-pertussis titers were determined. Patients in group 2 (on maintenance chemotherapy) and group 3 (patients not receiving therapy for 3-6 months) were vaccinated with diphtheria-tetanus with or without acellular pertussis; group 3 and control subjects were also given measles-mumps-rubella vaccine. Preimmunization and 1-month postimmunization titers were drawn. Preimmunization anti-diphtheria and anti-tetanus antibody titers between the groups and the controls were statistically similar. The seropositivity rate for anti-measles antibody in group 3 was significantly lower than controls. After vaccination, all of the patients developed protective anti-diphtheria and anti-tetanus antibody titers. The seroconversion rates of group 3 and controls for anti-measles and anti-mumps antibodies were statistically similar. The results showed that patients on maintenance therapy and after cessation of therapy made good antibody responses to diphtheria and tetanus toxoids, but response to measles and mumps vaccines was not as sufficient as toxoid vaccines. Children with ALL can receive the appropriate vaccines during and after maintenance treatment.


Subject(s)
Antibody Formation , Diphtheria-Tetanus-Pertussis Vaccine/therapeutic use , Measles Vaccine/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Rubella Vaccine/therapeutic use , Adolescent , Antineoplastic Agents/therapeutic use , Child , Child, Preschool , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Humans , Immunization/methods , Measles Vaccine/immunology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Reference Values , Rubella Vaccine/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...